The odontopathogenic virulence factor gingipain RgpB is produced as a zymogen to prevent intracellular activity prior to secretion.
during catalysis. The present results provide the structural determinants of zymogenic inhibition of RgpB by way of a novel inhibitory mechanism for peptidases in general and open the field for the design of novel inhibitory strategies in the treatment of human periodontal disease.
Periodontitis is a biofilm-associated chronic inflammatory disease of the gums caused by bacterial infection, which affects 10-15% of adults worldwide and may result in tooth loss (1, 2) . Of the several hundreds of bacterial species that colonize the oral cavity, the key disease pathogens are Aggregatibacter (Actinobacillus) actinomycetemcomitans, Tannerella forsythia, Treponema denticola, and Porphyromonas gingivalis, the latter three forming the red complex, which is implicated in severe forms of the disease (3) (4) (5) . P. gingivalis is an opportunistic pathogen found in up to 85% of periodontitis cases and its presence at the infection site is indicative of disease progression (6, 7) . The pathogen requires nutrients, such as heme or vitamin K, and anaerobic conditions for growth (2) . As part of the process of infection, P. gingivalis invades host epithelial cells and macrophages, where it affects cell-cycle pathways and suppresses apoptosis, thereby circumventing the host immune response and prolonging its survival (2, 8) . The pathogen possesses several factors which participate in infection, such as the lipopolysaccharide, the capsular polysaccharide, the fimbriae, and, most importantly, cysteine proteinases, viz. gingipains K (Kgp) and R (RgpA and RgpB) (2, 9, 10) . While the former factors are intrinsic components of the outer membrane of the pathogen, gingipains are true cellsurface-anchored or soluble virulence factors that, when secreted, account for up to 85% of the total extracellular proteolytic activity of P. gingivalis (10, 11) . This activity is aimed at obtaining nutrients, cleavage of host-cell surface receptors, stimulation of protease-activated receptor expression, and inactivation of cytokines and components of the complement system. These functions contribute to resistance of the pathogen to host bactericidal activity and maintenance of the chronic inflammatory condition at the site of infection (2) . In addition, gingipains contribute to bleeding and vascular permeability by activating plasma kallikrein, degrading fibrinogen, and increasing the levels of thrombin and prothrombin, thus increasing the availability of heme needed for bacterial growth (12) . These functions explain why gingipains are essential for bacterial survival and the pathological outcome of periodontitis (3, 10, 13) .
As occurs with most proteolytic enzymes, the activity of gingipains must be regulated to prevent undesired intracellular proteolysis yet yield full activity once secreted (14) . In general, such activity control occurs at the transcriptional level, through compartmentalization or allostery, or through inhibition by specific protein inhibitors. Another regulatory mechanism is zymogenic latency (15) , which is observed for gingipains, and is carried out mostly by N-terminal pro-peptides or prodomains (PDs). These usually prevent substrates from binding to the active-site cleft of the cognate catalytic domain (CD) and are mostly removed by limited proteolysis during maturation (15) (16) (17) . Such PDs often fold independently and guide on their part the folding process of the CD (18); they may also act as intra-molecular chaperones or inhibitors of the mature enzymes in transas described for RgpB (19)-and in the intracellular sorting of the zymogen (15) . Therefore, the study of the molecular mechanisms by which peptidases maintain latency is indispensable to the understanding of their basic mode of action. It also paves the way for the design of inhibitors that mimic the latent state so as to modulate proteolytic activity as part of a therapeutic approach. Detailed 3D structural information can contribute much to this understanding (20) .
Among gingipains, Kgp is specific for peptide bonds after lysines, while RgpA and RgpB are argininespecific (3, 21) . These enzymes are multi-domain proteins comprising at least a signal peptide, a PD, a CD, an immunoglobulin-superfamily domain (IgSF), and a Cterminal domain, as found in the 736-residue RgpB spanning, respectively, 24, 205, 351, 87, and 69 residues (3). RgpA has four additional hemagglutinin/adhesion domains (termed RgpA A1 -RgpA A4 ) inserted between the IgSF and the C-terminal domain, thus totaling 1,706 residues. Kgp may have between three and five such domains (termed KgpA A1 -KgpA A5 ) depending on the bacterial strain, thus totaling 1,723-1,732 residues (3). The CDs of gingipains distantly resemble caspase cysteine proteinases as revealed by the crystal structure of mature RgpB of P. gingivalis strain HG66 (22) , and are grouped into MEROPS database family C25 (http://merops.sanger.ac.uk; (23) ).
In order to understand the biochemical determinants of zymogenicity in gingipains, we analyzed the structure of the complex between the mature enzyme moiety (CD+IgSF domains) and the PD of RgpB from P. gingivalis strain W83. The results revealed a novel molecular mechanism of inhibition of peptidases and could thus pave the way for the design of novel inhibitory strategies that may help in palliating the effects of periodontal disease.
EXPERIMENTAL PROCEDURES
Protein production and complex formation -The wild-type PD of Porphyromonas gingivalis strain W83 gingipain R2 alias RgpB proteinase (see UniProt database access code P95493) was obtained as reported elsewhere. Briefly, the coding sequence (Q 25 -R 229 ) was cloned into the pGEX-6P-1 expression vector using BamHI/XhoI restriction sites, which attached an N-terminal glutathione-S-transferase-tag and a PreScission protease cleavage site. The vector was transformed into Escherichia coli BL21 (DE3) cells, and overexpression was induced with isopropyl-1-thio-β-Dgalactopyranoside. The protein was purified in a glutathione-Sepharose High Performance column, cleaved with PreScission protease, and passed again through glutathione-Sepharose.
The flow-through was concentrated by ultrafiltration. The final purified protein contained an N-terminal extension of GPLGS as the result of the cloning strategy. The CD plus the IgSF (residues Y 230 -G 662 ), fused to a C-terminal hexahistidine tag for purification, was purified from culture medium of the P. gingivalis strain W83 bearing a modified rgpB gene, in which a sequence encoding six histidine residues had been inserted in frame at the junction between the IgSF and the C-terminal domain. This construct results in the secretion of soluble RgpB with a C-terminal His-tag as described (24) . For complex formation, RgpB (15mg) was pre-activated in gel filtration buffer (50mM sodium phosphate, 0.15M sodium chloride, pH 7.2) freshly supplemented with 10mM L-cysteine for 10min. The activated RgpB-6xHis was then treated with 1mM N-[5-amino-L-1-(2-chloroacetyl)pentyl]-4-methylbenzenesulfonamide (TLCK).
After 10-15min preincubation, the PD was added in 1.5-molar excess with respect to RgpB and the reaction mixture was incubated for another 15min. All incubations were performed at room temperature. The complex was then separated from excess PD and TLCK by gel filtration on a Superdex 75 10/60 column (GE Health). The purity of the complex was evaluated by native PAGE and the protein concentration was determined by BCA assay (Sigma). The stability of the complex was assessed by following activity over time after incubation at 37ºC. No catalytic activity was observed after one week. This finding correlated well with purified full-length intact pro-RgpB undergoing auto-cleavage at the maturation site (R 229 -Y 230 ) but showing no significant catalytic activity even after two weeks of incubation.
Crystallization and structure determinationCrystallization assays were performed by the sitting-drop vapor diffusion method. Reservoir solutions were prepared by a Tecan robot and 100-nL crystallization drops were dispensed on 96x2-well MRC plates (Innovadyne) by a Phoenix nanodrop robot (Art Robbins) at the HighThroughput Crystallography Platform (PAC) at Barcelona Science Park. Plates were stored in Bruker steadytemperature crystal farms at 4°C and 20ºC. Successful conditions were scaled up to the microliter range with 24-well Cryschem crystallization dishes (Hampton Research Table 1 ).
The structure of the PD/CD+IgSF RgpB complex was solved by likelihood-scoring molecular replacement with program PHASER (26) (27) under fourfold averaging rendered an electron-density map which enabled construction of most of the 205-residue PD for one of the four complexes on a Silicon Graphics Octane2 Workstation using program TURBO-FRODO (28) . The position and orientation of the other three copies within the asymmetric unit were determined with PHASER. Subsequent model building alternated with crystallographic refinement with program BUSTER/TNT (29) ). Within each catalytic moiety, the CDs were much more rigid and better defined by proper electron density than the cognate IgSFs; within each CD, loop Lα7η3 (~530s) was flexible and traced based on weak electron density to preserve chain continuity. In addition to the protein chains, one Ba 2+ (tentatively assigned based on the electron density map and presence in the crystallization conditions) and three Ca 2+ cations were identified for each CD+IgSF moiety. Furthermore, in addition to a single magnesium and tris cation, two further tentatively-assigned calcium and three sodium cations, as well as one chloride anion, one glycerol molecule, and 858 solvent molecules completed the model. Each of the four catalytic cysteine residues (C 473 ) evinced extra electron density for its side chain, which we attribute to the purification strategy (see above) and conservatively interpreted as a methylsulfino group (residue type CSD). P 532 of chain H and two residues of each CD (S 449 and V 474 ) were the only Ramachandran outliers of the entire structure (see Table 1 ). The latter two were also outliers in the mature chloromethylketonecomplex structure (22) and are unambiguously defined by proper electron density. Superposition of the three complexes CD, EF, and GH onto AB, respectively, revealed 612 common Cα atoms deviating less than 3Å, which gave rise to rmsd values of 0.75Å, 0.55Å, and 0.48Å, respectively, and indicated close similarity of the structures. This was confirmed by an independent superposition of the four CDs, which revealed very similar orientations and positions for the cognate PDs, with just marginal displacements on the proteinase distal surface (max. 3.8Å at E 197 ). Accordingly, the four complexes were considered equivalent and the results and discussion hereafter refer to complex AB, which had slightly lower overall thermal displacement parameters (A/B: 41 (30) . Interaction surfaces (taken as half of the surface area buried at a complex interface) were calculated with CNS (31) . Structure similarities were investigated with DALI (32). Model validation was performed with MOLPROBITY (33) and the WHATCHECK routine of WHATIF (34) . The final coordinates of the complex between P. gingivalis RgpB PD and the CD+IgSF moiety have been deposited with the PDB at www.pdb.org (access code 4IEF).
RESULTS AND DISCUSSION
An experimental model of pro-RgpB -All attempts to crystallize intact full-length pro-RgpB for structural studies failed. Accordingly, the PD (residues Q 25 -R 229 ) and the mature moiety (residues Y 230 -G 662 ) of proRgpB from P. gingivalis strain W83 were produced separately and mixed to yield the zymogenic complex (see Experimental procedures). Four such complexes were found in the asymmetric unit of the crystal structure, which was determined by likelihood-scoring molecular replacement and averaging techniques, and refined with diffraction data to 2.3Å resolution (see Table 1 ). Superposition of the respective mature moieties revealed very similar relative arrangements of the four PDs. In addition, the distances (20-26Å) between the last residues of the PD moieties defined in the electron density (E 226 /R 229 ) and the first of the respective CDs (N 238 /G 239 ), both on the surface, could easily be bridged by the missing 8-11 residues running along the molecular surface. Accordingly, the present complex provides a bona fide model of the intact zymogen, which correlates well with the strong inhibitory capacity of the PD on CD+IgSF in trans. The biochemical and kinetic analysis of the interaction revealed a non-competitive mode of interaction leading to formation of the 1:1 stoichiometric complex, which was stable in native PAGE and size-exclusion chromatography.
The stability obeyed to an apparent inhibition constant in the low nanomolar range (K i =6.2±1.0nM). The very tight inhibitory interaction between the PD and the mature enzyme suggests existence of a yet unknown mechanism facilitating dissociation of the complex and degradation of the PD in vivo. At present we can only speculate on the nature of this mechanism. It can be related to glycosylation of the gingipain during the secretion process. Alternatively, one of the components of the PorSS secretion system, which is engaged in secretion of virulence factors for periodontopathogenicity (35) , could displace the PD during pro-RgpB translocation across the outer membrane and unleash activity.
A pro-domain with a novel fold -The PD is defined by the electron density for residues G 30 /R 31 -E 226 /R 229 and has the overall shape of a croissant with maximal dimensions ~60x35x20Å (Fig. 1A,B) . It consists of a central eleven-stranded β-core (strands βI-βXI) divided in two antiparallel β-sandwiches, 1 and 2, and decorated on the surface with an α-helix (αI) and two 3 10 -helices (ηI and ηII; see Fig. 1C,D Fig. 1C ). Sandwich 1 consists of a three-stranded back sheet (strands βV, βIX, and βVII+βVIII) and a four-stranded front sheet (strands βI, βII, βXI, and βVI; see Fig. 1C,D) . Strands βXI and βVI are N-and C-terminally extended beyond the limits of the sandwich, respectively, and bent by ~50-60º. In this manner, they also contribute to the three-stranded front sheet of sandwich 2 (strands βVI, βIX, and βX), which is packed against a two-stranded back sheet (strands βIII and βIV). The two sandwiches are roughly perpendicular to each other, both for the direction of the contributing strands and the planes of the sheets (Fig.  1C,D) . The strand connectivity of the two sandwiches is such that a first β-ribbon at the top of the front sheet of sandwich 1 (ribbon βIβII) is linked to the β-ribbon that creates the back sheet of sandwich 2 (βIIIβIV). This, in turn, ends in a loop connecting strands βIV and βV (LβIVβV), which is the top strand of the back sheet of sandwich 1. After βV, the chain enters the bottom strand of the front sheet of sandwich 1, βVI (Fig. 1C,D) , the second half of which is the top strand of the front sheet of sandwich 2. After βVI, a 39-residue loop segment runs across the bottom surface of PD. This loop includes 3 10 -helices ηI and ηII and encompasses a so-called "inhibitory loop" (see below; Fig. 1C ). This long loop leads to the bottom strand of the back sheet of sandwich 1, which is split in two, βVII and βVIII. The latter contributes to a β-ribbon together with the central back-sheet strand of sandwich 1, βIX. Thereafter, the polypeptide enters a β-ribbon (βXβXI), which creates the bottom of the front sheet of sandwich 2. As described for βVI, βXI is also extended and gives rise to the third strand (top to bottom) of the front sheet of sandwich 1 before leaving the β-core of the PD (Fig. 1C,D) . Thereafter, the chain passes through a flexible segment on the right surface, which is disordered at L 205 /V 206 -S 209 /T 210 and ends at the surface-located Cterminal helix αI on the back of sandwich 1, and finishes at E 226 /R 229 . Structural similarity searches identified agglutinin from the roman snail, Helix pomatia, as the closest structural relative of the PD (PDB 2CE6; (36); Z-score=6.3; rmsd=2.7Å for 89 common residues according to program DALI (37) ). This is a hexameric sugar-binding lectin from the albumen gland of the gastropod and part of its innate immune system. It belongs to a family of sugar-binding proteins mostly from invertebrates, which also includes discoidin C-terminal domain (PDB 2W94), and is a 3+3 pure β-sandwich. Upon superposition of the PD and agglutinin, it becomes evident that the latter resembles PD sandwich 1, both in connectivity and topology (Fig. 1E) . However, the PD shows an additional β-strand, the Nterminal βI, and, most importantly, the second sandwich and the unique loop structures including the two 3 10 -helices and the C-terminal α-helix. All-β domains similar to agglutinin are also present in glycolytic enzymes, i.e. sugar-binding proteins, such as endocellulase 9G (PDB 1G87), β-xylosidase (PDB 1W91), and endogluceramidase II (PDB 2OSX), as well as in the sugar-binding cellulosomal scaffolding protein A (PDB 4B9F), all of which were also identified as structurally related to the PD but match PD sandwich 1 only. We conclude that the PD of RgpB has a novel fold, hitherto unseen in peptidase zymogens and distantly related to functionally-unrelated sugar-binding proteins.
The mature enzyme moiety -The structure of the mature enzyme moiety within the zymogenic complex resembles a molar, with its crown, tooth body, and root. Its superposition onto the structure of a covalent complex of a closely-related mature enzyme moiety from a distinct bacterial strain with D-Phe-Phe-Arg-chloromethylketone (PDB 1CVR; (3, 22) ) reveals that, with the exception of some minor changes in side-chain conformations (see next section), the entire structure, including the active-site cleft and the surrounding moiety, is conserved, i.e. the zymogenic conformation of CD+IgSF induced by the PD reveals that the enzyme is probably in a competent conformation in the zymogen, as is often observed in peptidases, thus suggesting inhibition is mediated by competition with the substrate (38). Briefly, the CD (N 238 /G 239 -P 580 ) is subdivided into an N-terminal (or A-) sub-domain (NSD; N 238 /G 239 -E 345 ) and a C-terminal (or B-) sub-domain (CSD; S 346 -P 580 ). Both subdomains are α/β-moieties consisting of a central β-sheet, a four-stranded parallel one in the NSD and a six-stranded one parallel for all its strands except the outermost top one in the CSD (see Fig. 2B ; NSD on top, CSD at bottom). This strand contacts the NSD β-sheet in an approximately perpendicular manner (see also Fig. 2 in (22) ). NSD is decorated with one helix and two helices plus a short β-ribbon, respectively, on either side of the sheet. The CSD sheet has four helices and three helices plus a small three-stranded antiparallel β-sheet, respectively, on either side (Fig. 2B) . One calcium ion is found in both the NSD and the CSD (the latter cation is most likely a barium in the present zymogenic structure due to the crystallization conditions; see Experimental procedures), and a further one is present at the sub-domain interface (Fig. 2B) .
The active-site cleft is found at the "masticating surface" (22) of the molar crown and is formed by the CSD. As with enzymes with an α/β-hydrolase or PLEES fold (39, 40) , active-site residues are provided by loops and strands at the C-terminal edge of the central β-sheet, in this case that of the CSD: C 473 is donated by the loop after the fourth strand (bottom to top in Fig. 2B ), H 440 by the first strand of the small three-stranded sheet inserted after the third strand, and E 381 by a loop after the second strand. While cysteine-histidine dyads are common for cysteine proteinases, including MEROPS family C25 (41), the position and distance of E 381 to H 440 Nε2 in the mature enzyme (22) and in the present structure (Fig. 2B) suggests a role in protonation and, thus, side-chain orientation of the catalytic histidine during catalysis in RgpB, as described for an aspartate in the foot-and-mouth-disease-virus leader cysteine peptidase (42) . In the present structure, the catalytic cysteine displayed extra density for its side chain beyond its Sγ atom possibly due to the purification procedure, which included reversible covalent-inhibition steps, and which we conservatively interpreted as a methylsulfino side chain (see Experimental procedures). On the opposite surface to the molar crown-where the active site is located-, the downstream IgSF (T 581 -E 661 ) is inserted between the NSD and the CSD, thus mimicking the root of the molar. This domain is an antiparallel seven-stranded β-barrel or 3+4 β-sandwich, which contains a fourth calcium-binding site on the surface (Fig. 2A) . Its fold corresponds to that of classic immunoglobulin-like domains (43) as found in, e.g., α 2 -macroglobulin (44) .
Interaction between the pro-domain and the catalytic domain -By contrast with other zymogens that are inhibited by large, structured, globular domains, e.g. those of the metallocarboxypeptidase class (38), the PD does not frontally cover and shield the CD active-site cleft but, rather, attaches laterally through its concave croissant surface to the enzyme moiety ( Fig. 2A,B) . The interaction of the PD with the CD (no interaction is observed between the PD and the IgSF) occludes a surface of ~1,650Å 2 (~16% of the total PD surface), which is within the range generally described for protein-protein complexes (1,250-1,750Å 2 ; (45)). It shows a surface complementarity (Sc=0.75) that is likewise within the range reported for protein oligomers and protein/protein inhibitor interfaces (0.70-0.76; (46) (from LβXIαI and αI). In particular, I 159 O of PD replaces a solvent molecule binding the calcium ion of the NSD in the mature inhibitor-complex structure (PDB 1CVR; (22) 
Notwithstanding, the most relevant interaction of the pro-domain with the catalytic moiety is exerted by the inhibitory loop (K 121 -Y 135 ), which is part of the segment flanked by strand βVI and the 3 10 -helix ηII and is inserted like a stinger into the non-primed side of the active-site cleft, so that R 126 -A 127 occupies the position of a potential scissile bond. The inhibitory loop has a compact structure, which is contributed to by a tight 1,4-turn of type I (S 125 -E 128 ), 3 10 -helix ηI (N 129 -I 133 ), and a small hydrophobic core created by P 130 , I 133 , I 124 , and K 121 , which interacts with W 513 of the CD (Fig. 2D) . The lateral ζ-ammonium group of K 121 also contributes to the compact structure of the inhibitory loop through a double hydrogen bond with the main chain at P 130 and I 133 (Fig. 2D) . Superposition of the present zymogenic complex and the reported chloromethylketonebound enzyme, which mimics a substrate-bound form, reveals that segment I 124 -R 126 of the pro-domain binds to the active-site cleft in a substrate-like manner, i.e. in extended conformation and in the correct orientation. This binding places S 125 in cleft sub-site S 2 , I 124 in S 3 , and, most importantly, R 126 in S 1 , thus matching the specificity of RgpB (see Fig. 2C,D) (Fig. 3 ). This rotation, in turn, gives rise to a second strong hydrogen bond between one of the E 381 carboxylate oxygens and H 440 Nε2 (2.6-2.9Å). This interference with the catalytic residues most likely prevents cleavage of the PD at R 126 -A 127 . In addition, the polypeptide chain folds back after R 126 towards bulk solvent, so that the active-site cleft is free on its primed side, and this also leads the catalytic C 473 Sγ atom to be too far apart (3.7-3.8Å) from R 126 -A 127 . A novel mechanism of zymogenic inhibitionLatency maintenance in cysteine proteinases (17, 47) has been structurally studied for MEROPS family C1 members such as Carica papaya plant papain (48) and caricain (49) , and mammalian cathepsins B, K, L, S, and X (50-57). In these cases, the CD and the active-site cleft are, overall, in a preformed competent conformation in the zymogens and the ~60-100-residue PDs, which contain a globular part laterally attached to the CD, possess a C-terminal segment that runs across the entire active-site cleft in the opposite orientation to that of a substrate, thus blocking access to the cleft and preventing autolysis. Zymogens of family C14, in turn, include the structurally-studied mammalian caspases 1 (58); 3 (59); 7 (60, 61) , and 8 (62, 63) ; and the insect Drosophila caspase-9 ortholog DRONC (64) and Spodoptera frugiperda caspase-1 ortholog ((65) and PDB 2NN3). Caspases are oligomeric functional enzymes and activation cleavage entails major rearrangement of the loops flanking the activesite cleft from an incompetent to a competent conformation. There are no truly globular PDs but, rather, short N-terminal and/or internal peptides that are cleaved off during maturation, thus giving rise to two chains in the competent enzymes (60, 61, 66) . Zymogenic activation has been also studied for Staphylococcus aureus staphopain B (67), a member of family C47. Here, a large 183-residue globular PD based on a barrel-sandwich hybrid possesses a loop in the middle of the structure that binds, in the opposite orientation to that of substrates, to the cleft of an overall competent CD but only blocks the primed side of the cleft. Streptococcus pyogenes exotoxin B (alias SpeB or streptopain) (68) and Prevotella intermedia interpain A (69) belong to family C10, and here a backing-helix of a ~115-residue α/β-sandwich PD is inserted laterally into the cleft in the zymogen but does not completely block substrate access. Activation entails major rearrangement of a zymogenic hairpin and a latency flap, which leads to a large displacement of the catalytic histidine (69) .
In stark contrast, the description of the zymogenic complex of RgpB reported here demonstrates that the PD, the largest structurally-characterized to date for a cysteine peptidase with 205 residues, interacts laterally through a large surface with the CD. The distance from the activation cleavage site, R 229 -Y 230 , on the top back surface of the complex in Fig. 2B , to the catalytic cysteine, on the front bottom in Fig. 2B , is >40Å, strongly suggesting that cleavage and, thus, removal of the PD and activation of the CD occurs in trans, as previously suggested for the cysteine peptidase interpain A (69) . The PD intrudes into the activesite cleft through a structurally-cohered inhibitory loop in the middle of the domain, thus blocking access to nonprimed side of the cleft only. This mechanism is unlike previously reported ones and is thus unique for cysteine peptidases and peptidases in general. It will pave the way to designing small-molecule inhibitors that mimic the structure of the inhibitory loop and that inhibit RgpB in a non-covalent manner, and may contribute to the development of novel drugs to combat periodontitis.
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We are grateful to the Automated Crystallography Platform at IBMB/IRB/PCB for assistance during crystallization experiments. We acknowledge the help provided by local contacts at the ESRF synchrotron. Funding for data collection was provided in part by ESRF. 10 -helices in magenta and labeled αI and ηI-ηII, respectively; β-strand as blue arrows and labeled βI-βXI) and the approximate overall dimensions of the molecule. The inhibitory loop, which includes the S 1 -intruding residue, R 126 , is also labeled. Two small black arrows pinpoint the residues flanking the disordered segment preceding the C-terminal helix αI. (22)) in standard orientation. The two calcium ions (red spheres) and the barium ion (magenta sphere) found in the CD correspond to the zymogenic complex structure. Selected active-site residues are shown as sticks for each structure, as is the covalent inhibitor, atom-colored with green carbons. (alias R meas ) and R p.i.m. are improved multiplicityweighted indicators of the quality of the data, the redundancy-independent merging R factor and the precision-indicating merging R factor. The latter is computed after averaging over multiple measurements (for details, see (71, 72) ). b Crystallographic R factor = Σ hkl ||F obs | -k |F calc || / Σ hkl |F obs |, where k is a scaling factor, and F obs and F calc are the observed and calculated structure factor amplitudes, respectively. This factor is calculated for the working-set reflections; free R factor , same for a test-set of reflections (>500) not used during refinement. c According to MOLPROBITY (73) .
FOOTNOTES

